
GLP-1 Weight-Loss Drugs May Quietly Reshape Libido
GLP-1 medications such as semaglutide and tirzepatide, used for obesity and type 2 diabetes, may impact sexual function by altering brain reward pathways and serotonin signaling, potentially affecting desire, arousal, and pelvic-floor function. While some users report reduced appetite and increased energy or confidence that can improve sex life, others experience lowered libido. Research is still limited, but experts suggest effects vary by individual and may be temporary; adjustments to dosage, lifestyle, and open conversations with a clinician can help manage changes and support sexual well-being.











